Healthcare -
Biotechnology - NASDAQ - US
$ 2.625
1.74 %
$ 140 M
Market Cap
-2.76
P/E
TCRX - ACCOUNTS PAYABLE
Accounts Payable TCRX - TScan Therapeutics, Inc.
2.37 M
LAST VALUE
15.98%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR